Clinical trials
Completed Communicable Diseases trials with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
125 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 2 |
| 2003 | 2 |
| 2006 | 2 |
| 2008 | 3 |
| 2009 | 2 |
| 2010 | 3 |
| 2013 | 10 |
| 2015 | 3 |
| 2016 | 4 |
| 2017 | 6 |
| 2018 | 10 |
| 2019 | 14 |
| 2020 | 10 |
| 2021 | 17 |
| 2022 | 7 |
| 2023 | 11 |
| 2024 | 4 |
| 2025 | 7 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 125 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Center for Research Resources (NCRR) | 5 |
| Beneo-Institute | 3 |
| Kaiser Permanente | 3 |
| University of Washington | 3 |
| Centers for Disease Control and Prevention | 2 |
| Changhai Hospital | 2 |
| International Centre for Diarrhoeal Disease Research, Bangladesh | 2 |
| Johns Hopkins Bloomberg School of Public Health | 2 |
| Johns Hopkins University | 2 |
| Karolinska Institutet | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Communicable Diseases | 125 |
| Immune System Diseases | 10 |
| Rare Diseases | 10 |
| Obesity | 6 |
| Acquired Immunodeficiency Syndrome | 5 |
| COVID-19 | 5 |
| Respiratory Tract Infections | 5 |
| Pneumonia | 4 |
| Arthritis | 3 |
| Bacterial Infections | 3 |
Trials
Showing 1 to 25 of 125. Each trial links to its page on Pharma Observatory.
25 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.